Adenoviral transfer of vasoactive intestinal peptide (VIP) gene inhibits rat aortic and pulmonary artery smooth muscle cell proliferation.
Vasoactive intestinal peptide (VIP), a 28 amino acid peptide, has been shown to inhibit proliferation of vascular smooth muscle cells. In previous studies VIP and VIP analogs have been used to study the effects of the peptide on vascular smooth muscle cell function. In this study an adenovirus encoding the VIP gene was used to investigate the mechanism of the antiproliferative action of VIP in vascular smooth muscle cells. Primary cultures of aortic and pulmonary artery smooth muscle cells from male Sprague-Dawley rats were transfected with varying concentrations of serotype 5 adenovirus encoding human VIP (Ad5CMVhVIP). Transfection efficiency and subsequently VIP gene expression were confirmed by western blot analysis and immunohistochemistry. In this study a decrease in vascular smooth muscle cell proliferation at vector concentrations of 150, 300 and 600MOI (multiplicity of infection) was observed. In addition, there was increased production of cAMP in pulmonary artery and aortic smooth muscle cells transfected with VIP. Treatment of cells with a PKA inhibitor (Rp-8-BrcAMPs) restored proliferation to about 80% of control whereas treatment with the PKG inhibitor Rp-8-BrcGMPs had no significant effect suggesting the involvement of the PKA pathway in the antiproliferative actions of VIP.
St Hilaire
Rose-Claire
RC
Department of Pharmacology, Tulane University School of Medicine, 1430 Tulane Ave, New Orleans, LA 70112, USA.
Kadowitz
Philip J
PJ
Jeter
James R
JR
D015124:8-Bromo Cyclic Adenosine Monophosphate / Q000031:analogs & derivatives / Q000494:pharmacology; D000256:Adenoviridae / Q000235:genetics*; D000818:Animals; D015153:Blotting, Western; D049109:Cell Proliferation / Q000187:drug effects; D002470:Cell Survival / Q000187:drug effects / Q000235:genetics; D002478:Cells, Cultured; D017868:Cyclic AMP-Dependent Protein Kinases / Q000037:antagonists & inhibitors; D005822:Genetic Vectors; D006976:Hypertension, Pulmonary / Q000188:drug therapy; D007150:Immunohistochemistry; D008297:Male; D009131:Muscle, Smooth, Vascular / Q000166:cytology*; D032389:Myocytes, Smooth Muscle / Q000166:cytology* / Q000187:drug effects*; D051381:Rats; D017207:Rats, Sprague-Dawley; D013873:Thionucleotides / Q000494:pharmacology; D014660:Vasoactive Intestinal Peptide / Q000235:genetics / Q000502:physiology*
C105593:8-bromoadenosine-3',5'-cyclic monophosphorothioate; D013873:Thionucleotides; D015124:8-Bromo Cyclic Adenosine Monophosphate; D014660:Vasoactive Intestinal Peptide; D017868:Cyclic AMP-Dependent Protein Kinases
Eur J Hum Genet. 2007 Jan;15(1):18-22
17003842
Clin Physiol. 1993 Nov;13(6):677-85
8119061
Proc Natl Acad Sci U S A. 1976 Sep;73(9):3197-200
787988
J Pharmacol Exp Ther. 2005 Oct;315(1):370-81
15994369
Eur Respir J. 2008 Jan;31(1):135-9
18166594
Science. 1970 Sep 18;169(3951):1217-8
5450698
J Appl Physiol (1985). 1985 May;58(5):1723-8
3997734
Regul Pept. 1988 Aug;22(3):267-74
2902657
J Hypertens. 1996 Feb;14(2):209-13
8728298
J Clin Invest. 2003 May;111(9):1339-46
12727925
Mol Cells. 2006 Jun 30;21(3):337-42
16819295
Peptides. 1988 Jul-Aug;9(4):853-8
2852361
Biochem Biophys Res Commun. 2004 Jun 18;319(1):189-92
15158460
Blood Vessels. 1987;24(1-2):45-50
3567364
Pharmacol Ther. 1990;47(3):329-45
1963221
Am J Physiol Lung Cell Mol Physiol. 2005 Jan;288(1):L202-11
15257984
Circulation. 2007 Mar 13;115(10):1260-8
17309917
Cardiovasc Drug Rev. 2001 Fall;19(3):245-62
11607042
Atherosclerosis. 1995 Dec;118 Suppl:S51-6
8821465
In Vitro Cell Dev Biol. 1989 Jun;25(6):511-20
2661518
Am J Physiol. 1986 May;250(5 Pt 2):H755-60
3010741
Regul Pept. 2007 Mar 1;139(1-3):102-8
17174416
Eur Respir J. 1995 Dec;8(12):2129-38
8666110
Am J Physiol. 1995 Jun;268(6 Pt 1):L1047-51
7541947
Arterioscler Thromb Vasc Biol. 2000 Aug;20(8):1873-81
10938006
Regul Pept. 2003 Apr 15;112(1-3):115-20
12667632
Am J Physiol Cell Physiol. 2003 Jan;284(1):C191-9
12388111
Regul Pept. 2002 Oct 15;108(2-3):165-73
12220741
Cardiovasc Surg. 2002 Apr;10(2):138-45
11888743
Circulation. 2000 Feb 29;101(8):923-30
10694533
Science. 1994 Aug 5;265(5173):781-4
8047883